Related references
Note: Only part of the references are listed.Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations
Taisuke Kuroda et al.
EQUINE VETERINARY JOURNAL (2022)
Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia
Giorgia Galiazzo et al.
EQUINE VETERINARY JOURNAL (2022)
Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single-and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses
Alicia F. Yocom et al.
JOURNAL OF EQUINE VETERINARY SCIENCE (2022)
Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses
Megan R. Williams et al.
JOURNAL OF EQUINE VETERINARY SCIENCE (2022)
Pharmacokinetics of cannabidiol in a randomized crossover trial in senior horses
Shelley E. Turner et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2022)
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities
Lucia Grifoni et al.
MOLECULES (2022)
Safety and Efficacy of the Therapeutic Use of Cannabis-Based Products in the Treatment of Dogs: An Integrative Review
Diego Fontana de Andrade et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs
Sebastian Mejia et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2021)
Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
Manuel A. A. De Pra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Regenerative Medicine for Equine Musculoskeletal Diseases
Iris Ribitsch et al.
ANIMALS (2021)
Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses
Declan Ryan et al.
DRUG TESTING AND ANALYSIS (2021)
Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum
Giorgia Galiazzo et al.
JOURNAL OF EQUINE VETERINARY SCIENCE (2021)
Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses
Shelley Turner et al.
JOURNAL OF EQUINE VETERINARY SCIENCE (2021)
Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and Bioavailability
Sin Yin Lim et al.
PHARMACOTHERAPY (2020)
Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
Maria Fernandez-Trapero et al.
BIOMOLECULES (2020)
Investigation of plasma concentrations of paracetamol, metacetamol, and orthocetamol in Japanese racehorses using liquid chromatography-electrospray ionisation-tandem mass spectrometry
Hideaki Ishii et al.
DRUG TESTING AND ANALYSIS (2020)
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Chris D. Verrico et al.
PAIN (2020)
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
Valentina Franco et al.
CLINICAL PHARMACOKINETICS (2020)
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
Emilio Perucca et al.
CNS DRUGS (2020)
Study design synopsis: Designing and performing pharmacokinetic studies for systemically administered drugs in horses
Eden Bermingham et al.
EQUINE VETERINARY JOURNAL (2020)
Equine Drug Transporters: A Mini-Review and Veterinary Perspective
Brielle Rosa
PHARMACEUTICS (2020)
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro et al.
MOLECULES (2019)
A systematic review of cannabidiol dosing in clinical populations
S. A. Millar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The lower limit of quantification in pharmacokinetic analyses
Andrew Woodward et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2019)
Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs
Jianzhong Wang et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2019)
Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics
C. Bon et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2018)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship
Manuela Contin et al.
CLINICAL NEUROPHARMACOLOGY (2018)
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
Gemma Navarro et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial
Nadia Solowij et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
Lauri-Jo Gamble et al.
FRONTIERS IN VETERINARY SCIENCE (2018)
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model
Irina Cherniakov et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martinez-Pinilla et al.
FRONTIERS IN PHARMACOLOGY (2017)
Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics
J. E. Riviere et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2016)
Cannabinoids and Cytochrome P450 Interactions
Ondrej Zendulka et al.
CURRENT DRUG METABOLISM (2016)
In vitro studies on intestinal peptide transport in horses
A. Cehak et al.
JOURNAL OF ANIMAL SCIENCE (2013)
Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies
Yaning Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development
D. R. Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2012)
Polymeric micelles for oral drug delivery
Genevieve Gaucher et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review
Ivana Svizenska et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Free fatty acids have more potent effects on gastric emptying, gut hormones, and appetite than triacylglycerides
Tanya J. Little et al.
GASTROENTEROLOGY (2007)
Plasma clearance
PL Toutain et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Plasma terminal half-life
PL Toutain et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Share Paper
